ALVO

ALVO

USD

Alvotech Ordinary Shares

$4.830-0.260 (-5.108%)

Preço em tempo real

Healthcare
Drug Manufacturers - Specialty & Generic
Luxemburgo

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$5.090

Máximo

$5.100

Mínimo

$4.700

Volume

0.89M

Fundamentos da empresa

Capitalização de mercado

1.5B

Setor

Drug Manufacturers - Specialty & Generic

País

Luxembourg

Estatísticas de negociação

Volume médio

0.47M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $4.7Atual $4.830Máximo $13.7

Notícias relacionadas

GlobeNewswire

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO). The investigation concerns whether the

Ver mais
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
Analyst Upgrades

Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8

Deutsche Bank analyst Niall Alexander downgrades Alvotech from Buy to Hold and lowers the price target from $14 to $8.

Ver mais
Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8
GlobeNewswire

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today

Ver mais
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
GlobeNewswire

Alvotech Announces Changes in Global Business Development and Commercial Operations Team

REYKJAVIK, Iceland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced

Ver mais
Alvotech Announces Changes in Global Business Development and Commercial Operations Team

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.